Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
[Reference] JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]
Wang D(1), Hu B(1), Hu C(1), Zhu F(1), Liu X(1), Zhang J(1), Wang B(1),
Xiang H(1), Cheng Z(2), Xiong Y(3), Zhao Y(4), Li Y(5), Wang X(6), Peng Z(1).
[Median age] 56 years (range, 22-92 years).
[Sex] 54.3% were men (male).
[Symptoms] Fever (98.6%), fatigue (69.6%), dry cough (59.4%).
[Lab] Lymphopenia, prolonged prothrombin time, elevated lactate dehyrogenase (LDH).
[Radiologic study] bilateral patchy shadows or ground glass opacity on Chest CT scan.
[Treatment] Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy
(moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and
glucocorticoid therapy (62 [44.9%])
[Clinical progress] The median time from first symptom to dyspnea was 5.0 days,
to hospital admission was 7.0 days, and to ARDS was 8.0 days
[mortality rate] 4.3%.
'2019-nCoV, COVID-19' 카테고리의 다른 글
| Ethanol to Inactivate Coronaviruses (0) | 2020.03.05 |
|---|---|
| How to manage temperature & humidity to cope with Coronavirus 19? (2) | 2020.03.03 |
| What to eat against Novel Coronavirus? (0) | 2020.02.21 |
| Herbs with antiviral activity against Coronavirus (0) | 2020.02.18 |
| Novel Coronavirus (2019-nCoV): Plausible but feasible preventive food and nutrition in view of both the Bible and medicine (0) | 2020.02.01 |